NCT06992401View on ClinicalTrials.gov

Observational Study of Intranasal IVIG and RXRA Gene Expression in Long COVID Patients Undergoing Medical Tourism

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

July 15, 2029

Conditions
Post-Acute Sequelae of SARS-CoV-2 InfectionLong COVIDLong COVID FatigueLong COVID SyndromeCOVID 19 Associated CoagulopathyCOVID-19 Vaccination
Sponsors
All Listed Sponsors
lead

Healing Hope International

OTHER

NCT06992401 - Observational Study of Intranasal IVIG and RXRA Gene Expression in Long COVID Patients Undergoing Medical Tourism | Biotech Hunter | Biotech Hunter